AAAAAA

   
Results: 1-25 |
Results: 25
Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury
Authors: Banati, RB Cagnin, A Brooks, DJ Gunn, RN Myers, R Jones, T Birch, R Anand, P
Citation: Rb. Banati et al., Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury, NEUROREPORT, 12(16), 2001, pp. 3439-3442
Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers
Authors: Dagher, A Bleicher, C Aston, JAD Gunn, RN Clarke, PBS Cumming, P
Citation: A. Dagher et al., Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers, SYNAPSE, 42(1), 2001, pp. 48-53
Analyses of [F-18]altanserin bolus injection PET data. II: Consideration of radiolabeled metabolites in humans
Authors: Price, JC Lopresti, BJ Meltzer, CC Smith, GS Mason, NS Huang, Y Holt, DP Gunn, RN Mathis, CA
Citation: Jc. Price et al., Analyses of [F-18]altanserin bolus injection PET data. II: Consideration of radiolabeled metabolites in humans, SYNAPSE, 41(1), 2001, pp. 11-21
Positron emission tomography compartmental models
Authors: Gunn, RN Gunn, SR Cunningham, VJ
Citation: Rn. Gunn et al., Positron emission tomography compartmental models, J CEREBR B, 21(6), 2001, pp. 635-652
In-vivo measurement of activated microglia in dementia
Authors: Cagnin, A Brooks, DJ Kennedy, AM Gunn, RN Myers, R Turkheimer, FE Jones, T Banati, RB
Citation: A. Cagnin et al., In-vivo measurement of activated microglia in dementia, LANCET, 358(9280), 2001, pp. 461-467
In vivo visualization of activated glia by [C-11] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion
Authors: Cagnin, A Myers, R Gunn, RN Lawrence, AD Stevens, T Kreutzberg, GW Jones, T Banati, RB
Citation: A. Cagnin et al., In vivo visualization of activated glia by [C-11] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion, BRAIN, 124, 2001, pp. 2014-2027
PET measurement of the influence of corticosteroids on serotonin-1A receptor number
Authors: Montgomery, AJ Bench, CJ Young, AH Hammers, A Gunn, RN Bhagwagar, ZB Grasby, PM
Citation: Aj. Montgomery et al., PET measurement of the influence of corticosteroids on serotonin-1A receptor number, BIOL PSYCHI, 50(9), 2001, pp. 668-676
Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low
Authors: Rabiner, EA Bhagwagar, Z Gunn, RN Sargent, PA Bench, CJ Cowen, PJ Grasby, PM
Citation: Ea. Rabiner et al., Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low, AM J PSYCHI, 158(12), 2001, pp. 2080-2082
A statistical method for the analysis of positron emission tomography neuroreceptor ligand data
Authors: Aston, JAD Gunn, RN Worsley, KJ Ma, Y Evans, AC Dagher, A
Citation: Jad. Aston et al., A statistical method for the analysis of positron emission tomography neuroreceptor ligand data, NEUROIMAGE, 12(3), 2000, pp. 245-256
Quantitative analysis of [carbonyl-C-11]WAY-100635 PET studies
Authors: Gunn, RN Lammertsma, AA Grasby, PM
Citation: Rn. Gunn et al., Quantitative analysis of [carbonyl-C-11]WAY-100635 PET studies, NUCL MED BI, 27(5), 2000, pp. 477-482
Drug action at the 5-HT1A receptor in vivo: Autorecepror and postsynaptic receptor occupancy examined with PET and [carbonyl-C-11]WAY-100635
Authors: Rabiner, EA Gunn, RN Wilkins, MR Sargent, PA Mocaer, E Sedman, E Cowen, PJ Grasby, PM
Citation: Ea. Rabiner et al., Drug action at the 5-HT1A receptor in vivo: Autorecepror and postsynaptic receptor occupancy examined with PET and [carbonyl-C-11]WAY-100635, NUCL MED BI, 27(5), 2000, pp. 509-513
beta-blocker binding to human 5-HT1A receptors in vivo and in vitro: Implications for antidepressant therapy
Authors: Rabiner, EA Gunn, RN Castro, ME Sargent, PA Cowen, PJ Koepp, MJ Meyer, JH Bench, CJ Harrison, PJ Pazos, A Sharp, T Grasby, PM
Citation: Ea. Rabiner et al., beta-blocker binding to human 5-HT1A receptors in vivo and in vitro: Implications for antidepressant therapy, NEUROPSYCH, 23(3), 2000, pp. 285-293
Evaluation of [O-methyl-C-11]RS-15385-197 as a positron emission tomography radioligand for central alpha(2)-adrenoceptors
Authors: Hume, SP Hirani, E Opacka-Juffry, J Osman, S Myers, R Gunn, RN McCarron, JA Clark, RD Melichar, J Nutt, DJ Pike, VW
Citation: Sp. Hume et al., Evaluation of [O-methyl-C-11]RS-15385-197 as a positron emission tomography radioligand for central alpha(2)-adrenoceptors, EUR J NUCL, 27(5), 2000, pp. 475-484
Modeling dynamic PET-SPECT studies in the wavelet domain
Authors: Turkheimer, FE Banati, RB Visvikis, D Aston, JAD Gunn, RN Cunningham, VJ
Citation: Fe. Turkheimer et al., Modeling dynamic PET-SPECT studies in the wavelet domain, J CEREBR B, 20(5), 2000, pp. 879-893
On-line measurement of exhaled [C-11]CO2 during PET
Authors: Gunn, RN Ranicar, A Yap, JT Wells, P Osman, S Jones, T Cunningham, VJ
Citation: Rn. Gunn et al., On-line measurement of exhaled [C-11]CO2 during PET, J NUCL MED, 41(4), 2000, pp. 605-611
A general method to correct PET data for tissue metabolites using a dual-scan approach
Authors: Gunn, RN Yap, JT Wells, P Osman, S Price, P Jones, T Cunningham, VJ
Citation: Rn. Gunn et al., A general method to correct PET data for tissue metabolites using a dual-scan approach, J NUCL MED, 41(4), 2000, pp. 706-711
Thalamic microglial activation in ischemic stroke detected in vivo by PET and [C-11]PK11195
Authors: Pappata, S Levasseur, M Gunn, RN Myers, R Crouzel, C Syrota, A Jones, T Kreutzberg, GW Banati, RB
Citation: S. Pappata et al., Thalamic microglial activation in ischemic stroke detected in vivo by PET and [C-11]PK11195, NEUROLOGY, 55(7), 2000, pp. 1052-1054
The peripheral benzodiazepine binding site in the brain in multiple sclerosis - Quantitative in vivo imaging of microglia as a measure of disease activity
Authors: Banati, RB Newcombe, J Gunn, RN Cagnin, A Turkheimer, F Heppner, F Price, G Wegner, F Giovannoni, G Miller, DH Perkin, GD Smith, T Hewson, AK Bydder, G Kreutzberg, GW Jones, T Cuzner, ML Myers, R
Citation: Rb. Banati et al., The peripheral benzodiazepine binding site in the brain in multiple sclerosis - Quantitative in vivo imaging of microglia as a measure of disease activity, BRAIN, 123, 2000, pp. 2321-2337
Brain serotonin(1A) receptor binding measured by positron emission tomography with [C-11]WAY-100635 - Effects of depression and antidepressant treatment
Authors: Sargent, PA Kjaer, KH Bench, CJ Rabiner, EA Messa, C Meyer, J Gunn, RN Grasby, PM Cowen, PJ
Citation: Pa. Sargent et al., Brain serotonin(1A) receptor binding measured by positron emission tomography with [C-11]WAY-100635 - Effects of depression and antidepressant treatment, ARCH G PSYC, 57(2), 2000, pp. 174-180
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
Authors: Piccini, P Brooks, DJ Bjorklund, A Gunn, RN Grasby, PM Rimoldi, O Brundin, P Hagell, P Rehncrona, S Widner, H Lindvall, O
Citation: P. Piccini et al., Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient, NAT NEUROSC, 2(12), 1999, pp. 1137-1140
Assessment of spatial normalization of PET ligand images using ligand-specific templates
Authors: Meyer, JH Gunn, RN Myers, R Grasby, PM
Citation: Jh. Meyer et al., Assessment of spatial normalization of PET ligand images using ligand-specific templates, NEUROIMAGE, 9(5), 1999, pp. 545-553
Steps to a neurochemistry of personality
Authors: Lawrence, AD Koepp, MJ Gunn, RN Cunningham, VJ Grasby, PM
Citation: Ad. Lawrence et al., Steps to a neurochemistry of personality, BEHAV BRAIN, 22(3), 1999, pp. 528
[C-11](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis
Authors: Banati, RB Goerres, GW Myers, R Gunn, RN Turkheimer, FE Kreutzberg, GW Brooks, DJ Jones, T Duncan, JS
Citation: Rb. Banati et al., [C-11](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis, NEUROLOGY, 53(9), 1999, pp. 2199-2203
Huntington's disease progression PET and clinical observations
Authors: Andrews, TC Weeks, RA Turjanski, N Gunn, RN Watkins, LHA Sahakian, B Hodges, JR Rosser, AE Wood, NW Brooks, DJ
Citation: Tc. Andrews et al., Huntington's disease progression PET and clinical observations, BRAIN, 122, 1999, pp. 2353-2363
Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-C-11]WAY-100635 for PET
Authors: Gunn, RN Sargent, PA Bench, CJ Rabiner, EA Osman, S Pike, VW Hume, SP Grasby, PM Lammertsma, AA
Citation: Rn. Gunn et al., Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-C-11]WAY-100635 for PET, NEUROIMAGE, 8(4), 1998, pp. 426-440
Risultati: 1-25 |